External Source

An Update On Amg 330: Can Bites Be As Successful In Aml As All?

2018 1:57
Synopsis
After several successes in the acute lymphoblastic leukemia (ALL) setting, bi-specific T-cell engager (BiTE) therapies are now ...

You Might Also Like

Updates from AMG 330 in AML 4:16
Updates From Amg 330 In Aml
2020
BiTES for the treatment of acute myeloid leukemia (AML) - results with AMG 330 in ex vivo study 1:44
Bites For The Treatment Of Acute Myeloid Leukemia (aml) - Re...
2017
Update on AMG 330 bispecific for R/R AML 1:38
Update On Amg 330 Bispecific For R/r Aml
2019
Findings For the BiTE Antibody AMG 330 in Relapsed/Refractory AML 1:40
Findings For The Bite Antibody Amg 330 In Relapsed/refractor...
2018
Phase I study of AMG-330: a BiTe for R/R AML patients 5:19
Phase I Study Of Amg-330: A Bite For R/r Aml Patients
2020
An update on the state-of-affairs of BiTEs in the world of AML 1:21
An Update On The State-of-affairs Of Bites In The World Of A...
2018
Rationale for Phase I Study of AMG 330 in Relapsed/Refractory AML 1:26
Rationale For Phase I Study Of Amg 330 In Relapsed/refractor...
2018
Exciting immunotherapy clinical trials for the management of AML 1:24
Exciting Immunotherapy Clinical Trials For The Management Of...
2018
AMG 330: an anti-CD33 bispecific T-Cell engager antibody construct in relapsed/refractory AML 3:35
Amg 330: An Anti-cd33 Bispecific T-cell Engager Antibody Con...
2019
Antibodies for AML: updates from ASH 1:40
Antibodies For Aml: Updates From Ash
2019
AMG 673: novel half-life extended anti-CD33/CD3 BiTE in R/R AML 2:23
Amg 673: Novel Half-life Extended Anti-cd33/cd3 Bite In R/r ...
2020
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.